Top Markets
Coin of the day
Huaren Pharmaceutical Co., Ltd. Huaren Pharmaceutical Co., Ltd.

Huaren Pharmaceutical Co., Ltd.

300110
Kedudukan dalam Saham #13339
Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions... Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and sugar metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, it offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. The company was founded in 1998 and is based in Qingdao, China.
Harga Saham
$0.42025026
Modal Pasaran
$496.83M
Perubahan (1 hari)
-2.03%
Perubahan (1 tahun)
-10.01%
Negara
CN
Perdagangan Huaren Pharmaceutical Co., Ltd. (300110)

Kategori

Nisbah P/B bagi Huaren Pharmaceutical Co., Ltd. (300110)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Huaren Pharmaceutical Co., Ltd., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Huaren Pharmaceutical Co., Ltd. dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa